Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 7/2015

01-07-2015 | Letter

High-dose versus standard dose oseltamivir for treatment of severe influenza in adult intensive care unit patients

Authors: Sarah C. Welch, Simon W. Lam, Elizabeth A. Neuner, Seth R. Bauer, Stephanie N. Bass

Published in: Intensive Care Medicine | Issue 7/2015

Login to get access

Excerpt

Dear Editor, …
Appendix
Available only for authorised users
Literature
1.
Prevention Centers for Disease Control and Prevention (2011) Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 60:1–25
2.
Lee N, Hui DS, Zuo Z, Ngai KL, Lui GC et al (2013) A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections. Clin Infect Dis 57:1511–1519PubMedCrossRef
3.
South East Asia Infectious Disease Clinical Research Network (2013) Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial. BMJ 346:f3039PubMedCentralCrossRef
4.
Yen HL, Monto AS, Webster RG, Govorkova EA (2005) Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J Infect Dis 192:665–672PubMedCrossRef
5.
Ariano RE, Sitar DS, Zelenitsky SA, Zarychanski R, Pisipati A et al (2010) Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. CMAJ 182:357–363PubMedCentralPubMedCrossRef
Metadata
Title
High-dose versus standard dose oseltamivir for treatment of severe influenza in adult intensive care unit patients
Authors
Sarah C. Welch
Simon W. Lam
Elizabeth A. Neuner
Seth R. Bauer
Stephanie N. Bass
Publication date
01-07-2015
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 7/2015
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-015-3816-z

Other articles of this Issue 7/2015

Intensive Care Medicine 7/2015 Go to the issue

What's New in Intensive Care

Ten things you should consider before you believe a clinical practice guideline

Correspondence

Acute mesenteric ischemia, procalcitonin, and intensive care unit

Seven-Day Profile Publication

Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial

Letter

Training in trains: an educational program to teach bystander CPR

Original

More than half the families of mobile intensive care unit patients experience inadequate communication with physicians

Editorial

High-flow nasal cannula following extubation: is more oxygen flow useful after surgery?